Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes

Nature Immunology volume 11, pages 442–448 (2010)Cite this article

Subjects

Abstract

The CD4 versus CD8 lineage specification of thymocytes is linked to coreceptor expression. The transcription factor MAZR has been identified as an important regulator of Cd8 expression. Here we show that variegated CD8 expression by loss of Cd8 enhancers was reverted in MAZR-deficient mice, which confirms that MAZR negatively regulates the Cd8 loci during the transition to the double-positive (DP) stage. Moreover, loss of MAZR led to partial redirection of major histocompatibility complex (MHC) class I–restricted thymocytes into CD4+ helper-like T cells, which correlated with derepression of Th-POK, a central transcription factor for helper-lineage development. MAZR bound the silencer of the gene encoding Th-POK, which indicated direct regulation of this locus by MAZR. Thus, MAZR is part of the transcription factor network that regulates the CD8 lineage differentiation of DP thymocytes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Altered ratio of CD4+ T cells to CD8+ T cells in the absence of MAZR.
Figure 2: Less variegation of CD8 in mice doubly deficient in E8I and E8II in the absence of MAZR.
Figure 3: T cell–intrinsic defects lead to an altered ratio of CD4+ cells to CD8+ cells in Mazr−/− mice.
Figure 4: T cell development in MHC class I– and class II–restricted TCR-transgenic mice in the absence of MAZR.
Figure 5: Redirected differentiation of MHC class I–restricted thymocytes into helper lineage cells in the absence of MAZR.
Figure 6: Derepression of Th-POK in Mazr−/−Rag2−/− OT-I thymocytes and CD8+ T cells.
Figure 7: Derepression of Th-POK in MHC class I–signaled Mazr−/− thymocytes.

References

  1. Bosselut, R. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4, 529–540 (2004).

    Article  CAS  Google Scholar 

  2. He, X. & Kappes, D.J. CD4/CD8 lineage commitment: light at the end of the tunnel? Curr. Opin. Immunol. 18, 135–142 (2006).

    Article  CAS  Google Scholar 

  3. Singer, A., Adoro, S. & Park, J.H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8, 788–801 (2008).

    Article  CAS  Google Scholar 

  4. Ellmeier, W., Sawada, S. & Littman, D.R. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu. Rev. Immunol. 17, 523–554 (1999).

    Article  CAS  Google Scholar 

  5. Kioussis, D. & Ellmeier, W. Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nat. Rev. Immunol. 2, 909–919 (2002).

    Article  CAS  Google Scholar 

  6. Ellmeier, W., Sunshine, M.J., Maschek, R. & Littman, D.R. Combined deletion of CD8 locus cis-regulatory elements affects initiation but not maintenance of CD8 expression. Immunity 16, 623–634 (2002).

    Article  CAS  Google Scholar 

  7. Garefalaki, A. et al. Variegated expression of CD8α resulting from in situ deletion of regulatory sequences. Immunity 16, 635–647 (2002).

    Article  CAS  Google Scholar 

  8. Feik, N. et al. Functional and molecular analysis of the double-positive stage-specific CD8 enhancer E8III during thymocyte development. J. Immunol. 174, 1513–1524 (2005).

    Article  CAS  Google Scholar 

  9. Bilic, I. et al. Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR. Nat. Immunol. 7, 392–400 (2006).

    Article  CAS  Google Scholar 

  10. Taniuchi, I., Ellmeier, W. & Littman, D.R. The CD4/CD8 lineage choice: new insights into epigenetic regulation during T cell development. Adv. Immunol. 83, 55–89 (2004).

    Article  CAS  Google Scholar 

  11. Bilic, I. & Ellmeier, W. The role of BTB domain-containing zinc finger proteins in T cell development and function. Immunol. Lett. 108, 1–9 (2007).

    Article  CAS  Google Scholar 

  12. Kelly, K.F. & Daniel, J.M. POZ for effect–POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 16, 578–587 (2006).

    Article  CAS  Google Scholar 

  13. Kobayashi, A. et al. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol. Cell. Biol. 20, 1733–1746 (2000).

    Article  CAS  Google Scholar 

  14. Fedele, M. et al. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J. Pathol. 215, 39–47 (2008).

    Article  CAS  Google Scholar 

  15. He, X. et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433, 826–833 (2005).

    Article  CAS  Google Scholar 

  16. Sun, G. et al. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6, 373–381 (2005).

    Article  CAS  Google Scholar 

  17. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34–40 (1998).

    Article  CAS  Google Scholar 

  18. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17–27 (1994).

    Article  CAS  Google Scholar 

  19. Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621–633 (2002).

    Article  CAS  Google Scholar 

  20. Setoguchi, R. et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825 (2008).

    Article  CAS  Google Scholar 

  21. Egawa, T. & Littman, D.R. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat. Immunol. 9, 1131–1139 (2008).

    Article  CAS  Google Scholar 

  22. Wang, L. et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells. Nat. Immunol. 9, 1122–1130 (2008).

    Article  CAS  Google Scholar 

  23. Aliahmad, P. & Kaye, J. Development of all CD4 T lineages requires nuclear factor TOX. J. Exp. Med. 205, 245–256 (2008).

    Article  CAS  Google Scholar 

  24. Egawa, T., Tillman, R.E., Naoe, Y., Taniuchi, I. & Littman, D.R. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204, 1945–1957 (2007).

    Article  CAS  Google Scholar 

  25. Muroi, S. et al. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat. Immunol. 9, 1113–1121 (2008).

    Article  CAS  Google Scholar 

  26. He, X. et al. CD4–CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus. Immunity 28, 346–358 (2008).

    Article  CAS  Google Scholar 

  27. Jepsen, K. & Rosenfeld, M.G. Biological roles and mechanistic actions of co-repressor complexes. J. Cell Sci. 115, 689–698 (2002).

    CAS  PubMed  Google Scholar 

  28. Taniuchi, I. Transcriptional regulation in helper versus cytotoxic-lineage decision. Curr. Opin. Immunol. 21, 127–132 (2009).

    Article  CAS  Google Scholar 

  29. Collins, A., Littman, D.R. & Taniuchi, I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 9, 106–115 (2009).

    Article  CAS  Google Scholar 

  30. Egawa, T. Runx and ThPOK: A balancing act to regulate thymocyte lineage commitment. J. Cell. Biochem. 107, 1037–1045 (2009).

    Article  CAS  Google Scholar 

  31. Wang, L. et al. The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity 29, 876–887 (2008).

    Article  Google Scholar 

  32. Jenkinson, S.R. et al. Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4–CD8 lineage differentiation. J. Exp. Med. 204, 267–272 (2007).

    Article  CAS  Google Scholar 

  33. Zou, Y.R. et al. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat. Genet. 29, 332–336 (2001).

    Article  CAS  Google Scholar 

  34. Leung, R.K. et al. Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Nat. Immunol. 2, 1167–1173 (2001).

    Article  CAS  Google Scholar 

  35. Liu, X. & Bosselut, R. Duration of TCR signaling controls CD4–CD8 lineage differentiation in vivo. Nat. Immunol. 5, 280–288 (2004).

    Article  CAS  Google Scholar 

  36. Naoe, Y. et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbfβ binding to the Il4 silencer. J. Exp. Med. 204, 1749–1755 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M. Sibilia (Medical University of Vienna) for OT-I TCR-transgenic mice; D. Stoiber-Sakaguchi (Medical University of Vienna) for OT-II TCR-transgenic mice; W. Held (Glaxo) for recombinant human interleukin 2; J. Kaye for information about primer sequences that detect Tox expression; M. Willheim and G. Hofbauer for cell sorting; H. Tanaka for technical advice; E. Pfeiffer for help with irradiation; M. Busslinger for help with some animal experiments; D. Stoiber-Sakaguchi, J. Raberger and N. Boucheron for critical reading of the manuscript; and the National Institutes of Health Tetramer facility for CD1d reagents with and without PBS57. Supported by the Austrian Science Fund (P16708 and P19930), the START Program of the Austrian Ministry of Science and Research (project Y-163), the RIKEN Research Center for Allergy and Immunology (International Collaboration Program) and the Ernst Schering Foundation (M.H.).

Author information

Author notes

  1. Yoshinori Naoe

    Present address: Department of Mechanism of Aging, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Obu, Japan (Y.N.).,

  2. Ivan Bilic

    Present address: Present addresses: Research Institute of Molecular Pathology, 1030 Vienna, Austria (I.B.).,

  3. Matthias Hombauer and Ivan Bilic: These authors contributed equally to this work.

Authors and Affiliations

  1. Division of Immunobiology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria

    Shinya Sakaguchi, Matthias Hombauer, Ivan Bilic, Alexandra Schebesta & Wilfried Ellmeier

  2. Laboratory for Transcriptional Regulation, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan

    Yoshinori Naoe & Ichiro Taniuchi

Authors
  1. Shinya Sakaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Hombauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivan Bilic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshinori Naoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexandra Schebesta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ichiro Taniuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wilfried Ellmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.S. designed the research, did most of the experiments, analyzed the data and wrote the manuscript; M.H. did coimmunoprecipitation and ChIP assays; A.S. and Y.N. did ChIP assays; I.B. contributed to the generation of Mazr-deficient mice and did some of the bone marrow–transplantation experiments; I.T. provided reagents and experimental mice and contributed to the design of the research; and W.E. designed the research, contributed to the generation of Mazr-deficient mice, analyzed the data and wrote the manuscript.

Corresponding author

Correspondence to Wilfried Ellmeier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–11 and Supplementary Table 1 (PDF 3065 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sakaguchi, S., Hombauer, M., Bilic, I. et al. The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes. Nat Immunol 11, 442–448 (2010). https://doi.org/10.1038/ni.1860

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.1860

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing